You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Temozolomide Monotherapy for the Treatment of Patients with Glioblastoma that has Relapsed or Progressed Following Prior Therapy

ID: CED 20 Mar 2011
Type of Content: Guidelines & Advice, Clinical
Document Status: Archived
J. Perry, W. Mason, D. Macdonald, A.E. Haynes